Resmed (RMD) Shares Outstanding (2009 - 2026)

Resmed's Shares Outstanding (Entity) history runs 18 years deep, the most recent figure standing at $145.3 million for Q1 2026.

• Quarterly Shares Outstanding (Entity) fell 0.94% year-over-year to $145.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $145.3 million (down 0.94% YoY) and the FY2025 annual result came in at $146.7 million, changed 0.21% from the prior year.
• Shares Outstanding (Entity) was $145.3 million for Q1 2026 at Resmed, roughly flat from $145.8 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $147.1 million in Q4 2023 and bottomed at $145.3 million in Q1 2026.
• A 5-year average of $146.6 million and a median of $146.7 million in 2025 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) grew 0.52% — and 2026, when it fell 0.94%.
• Resmed's Shares Outstanding (Entity) stood at $146.7 million in 2022, then increased by 0.29% to $147.1 million in 2023, then fell by 0.22% to $146.8 million in 2024, then decreased by 0.66% to $145.8 million in 2025, then retreated by 0.34% to $145.3 million in 2026.
• Business Quant data shows RMD's Shares Outstanding (Entity) at $145.3 million in Q1 2026, $145.8 million in Q4 2025, and $146.2 million in Q3 2025.